Why Should We Become Posthuman? The Beneficence Argument Questioned.

critical posthumanism directed evolution human enhancement metaethics posthumanity transhumanism

Journal

The Journal of medicine and philosophy
ISSN: 1744-5019
Titre abrégé: J Med Philos
Pays: United States
ID NLM: 7610512

Informations de publication

Date de publication:
16 Mar 2019
Historique:
entrez: 17 3 2019
pubmed: 17 3 2019
medline: 16 7 2020
Statut: ppublish

Résumé

Why should we become posthuman? There is only one morally compelling answer to this question: because posthumanity will be a more beneficial state, better than present humanity. This is the Posthuman Beneficence Argument (PBA), the centerpiece of the liberal transhumanist defense of "directed evolution." In this article, I examine PBA and find it deficient on a number of lethal counts. My argument focuses on the writings of transhumanist philosopher Nick Bostrom, who has developed the most articulate defense of PBA and disclosed its metaethical framework. I begin by locating PBA in the context of wider transhumanist claims for the desirability of posthumanity. I identify two crucial components: (1) a model of deliberative rationality, requiring reasons to endorse claims; and (2) the reasons themselves (i.e., the greater beneficence that posthumanity represents). I examine these two conditions, in turn, specifying the claims that they ask us to accept. Following Bostrom, I argue that there is a need for a foundationalist approach that assures us of some universality in the process of valuation. This is required to appropriately ground the moral continuity and appeal to universality that PBA demands. I examine the reasons why this approach ultimately fails, leaving posthumanity as an unintelligible concept with no moral force. I conclude by identifying (and endorsing) a more mature approach to the debate on human enhancement, one that forfeits the grandiose but baseless claims too often found in transhumanist defenses of directed evolution. In short, posthumanity may be a good science fiction trope, but it has no normative force in the moral philosophy of human enhancement.

Identifiants

pubmed: 30877776
pii: 5381978
doi: 10.1093/jmp/jhy041
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

192-219

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press, on behalf of the Journal of Medicine and Philosophy Inc. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Andrés Pablo Vaccari (A)

Macquarie University, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH